Multnomah Arts Center
7688 SW Capitol Hwy
Portland, OR 97219
October 3 & 4, 2020
9:30AM - 4:30PM PDT
Elizabeth Nielson & Ingmar Gorman
Optional CE Certificate $50
This 2-day training offered by psychologists Ingmar Gorman and Elizabeth Nielson is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice, including how to work with patients who have a history of psychedelic use or have expressed an interest in using psychedelics. This interactive training includes role plays, demonstrations, case examples, and experiential learning opportunities.
This workshop has an enrollment limited to 60 participants. Lead trainers Drs Gorman & Nielson as well as 2 assisting trainers will be present. This workshop has been offered nationally and internationally over 10 times in the last 2 years and has routinely sold out and generated a waiting list. Upon completion, participants will be offered the opportunity to join the presenters’ google group with over 500 past program participants for networking and continued collaboration.
Psychedelics 101: Your patients are curious and so are you: What is all this about psychedelics being used for treatment of addiction and trauma? This session gives an overview of psychedelic drugs, their history, and current research with MDMA and Psilocybin-assisted therapy. This program includes an overview of recent and current clinical trials, outcomes, legal status, and what it all means for the future of addiction and trauma treatment.
Psychedelics 102: This day introduces clinical skills for psychedelic harm reduction and integration work in the clinical setting. This program focuses on translating research findings into clinical practice including working with patients who are considering using psychedelics, actually using psychedelics, or have used them. Includes discussion of assessment and integration techniques, resources, and legal and ethical issues.
Fundraising: This workshop is a fundraiser for an upcoming randomized trial for MDMA-assisted therapy for social anxiety disorder to be conducted in conjunction with Portland Psychotherapy and MAPS. ALL profits from this workshop will go to support that trial.